Dedifferentiation and Reprogramming: Origins of Cancer Stem Cells

Overview

Journal EMBO Rep

Specialty Molecular Biology

Date 2014 Feb 18

PMID 24531722

Citations 281

Authors

Dinorah Friedmann-Morvinski

Inder M Verma

Affiliations

Soon will be listed here.

Abstract

Regenerative medicine aims to replace the lost or damaged cells in the human body through a new source of healthy transplanted cells or by endogenous repair. Although human embryonic stem cells were first thought to be the ideal source for cell therapy and tissue repair in humans, the discovery by Yamanaka and colleagues revolutionized the field. Almost any differentiated cell can be sent back in time to a pluripotency state by expressing the appropriate transcription factors. The process of somatic reprogramming using Yamanaka factors, many of which are oncogenes, offers a glimpse into how cancer stem cells may originate. In this review we discuss the similarities between tumor dedifferentiation and somatic cell reprogramming and how this may pose a risk to the application of this new technology in regenerative medicine.

Citing Articles

Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation.

He L, Azizad D, Bhat K, Ioannidis A, Hoffmann C, Arambula E Proc Natl Acad Sci U S A. 2025; 122(9):e2415557122.

PMID: 40009641 PMC: 11892679. DOI: 10.1073/pnas.2415557122.

Prognostic significance and multidimensional roles of interferon regulatory factors in cancer biology: A comprehensive analysis.

Ji G, Xian S, Song J, Mao S, Pi M, Huang Q Genes Dis. 2025; 12(3):101426.

PMID: 39897128 PMC: 11786875. DOI: 10.1016/j.gendis.2024.101426.

Diffusion Smart-seq3 of breast cancer spheroids to explore spatial tumor biology and test evolutionary principles of tumor heterogeneity.

Cougnoux A, Mahmoud L, Johnsson P, Eroglu A, Gsell L, Rosenbauer J Sci Rep. 2025; 15(1):3811.

PMID: 39885179 PMC: 11782488. DOI: 10.1038/s41598-024-83989-x.

Differential cell architecture and microenvironmental responses of pretumoral and tumoral cellular models exposed to coverslip-induced hypoxia.

Millan M, Parietti F, Lamela F, De Rossi M, Benitez B, Levi V Histochem Cell Biol. 2025; 163(1):23.

PMID: 39751684 DOI: 10.1007/s00418-024-02350-5.

The roles of cancer stem cells and therapeutic implications in melanoma.

Mu X, Zhou Y, Yu Y, Zhang M, Liu J Front Immunol. 2024; 15:1486680.

PMID: 39611156 PMC: 11602477. DOI: 10.3389/fimmu.2024.1486680.

References

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

Morris S, Daley G . A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res. 2013; 23(1):33-48. PMC: 3541663. DOI: 10.1038/cr.2013.1. View

Gupta P, Chaffer C, Weinberg R . Cancer stem cells: mirage or reality?. Nat Med. 2009; 15(9):1010-2. DOI: 10.1038/nm0909-1010. View

Vermeulen L, de Sousa E Melo F, van der Heijden M, Cameron K, de Jong J, Borovski T . Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010; 12(5):468-76. DOI: 10.1038/ncb2048. View

Chaffer C, Brueckmann I, Scheel C, Kaestli A, Wiggins P, Rodrigues L . Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A. 2011; 108(19):7950-5. PMC: 3093533. DOI: 10.1073/pnas.1102454108. View

Sommer C, Mostoslavsky G . The evolving field of induced pluripotency: recent progress and future challenges. J Cell Physiol. 2012; 228(2):267-75. DOI: 10.1002/jcp.24155. View

Schwitalla S, Fingerle A, Cammareri P, Nebelsiek T, Goktuna S, Ziegler P . Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell. 2013; 152(1-2):25-38. DOI: 10.1016/j.cell.2012.12.012. View

Marchetto M, Yeo G, Kainohana O, Marsala M, Gage F, Muotri A . Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One. 2009; 4(9):e7076. PMC: 2741600. DOI: 10.1371/journal.pone.0007076. View

Newman A, Cooper J . Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell. 2010; 7(2):258-62. DOI: 10.1016/j.stem.2010.06.016. View

10.

Baylin S, Jones P . A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011; 11(10):726-34. PMC: 3307543. DOI: 10.1038/nrc3130. View

11.

Chin M, Mason M, Xie W, Volinia S, Singer M, Peterson C . Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009; 5(1):111-23. PMC: 3448781. DOI: 10.1016/j.stem.2009.06.008. View

12.

Vredenburgh J, Desjardins A, Herndon 2nd J, Dowell J, Reardon D, Quinn J . Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res. 2007; 13(4):1253-9. DOI: 10.1158/1078-0432.CCR-06-2309. View

13.

Friedmann-Morvinski D, Bushong E, Ke E, Soda Y, Marumoto T, Singer O . Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science. 2012; 338(6110):1080-4. PMC: 3595315. DOI: 10.1126/science.1226929. View

14.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

15.

Gonzalez F, Boue S, Izpisua Belmonte J . Methods for making induced pluripotent stem cells: reprogramming à la carte. Nat Rev Genet. 2011; 12(4):231-42. DOI: 10.1038/nrg2937. View

16.

Ohi Y, Qin H, Hong C, Blouin L, Polo J, Guo T . Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol. 2011; 13(5):541-9. PMC: 3987913. DOI: 10.1038/ncb2239. View

17.

Linhart H, Lin H, Yamada Y, Moran E, Steine E, Gokhale S . Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev. 2007; 21(23):3110-22. PMC: 2081977. DOI: 10.1101/gad.1594007. View

18.

Kaiser L . The future of multihospital systems. Top Health Care Financ. 1992; 18(4):32-45. View

19.

de Resende M, Chinen L, Vieira S, Jampietro J, da Fonseca F, Vassallo J . Prognostication of OCT4 isoform expression in prostate cancer. Tumour Biol. 2013; 34(5):2665-73. DOI: 10.1007/s13277-013-0817-9. View

20.

Visvader J . Cells of origin in cancer. Nature. 2011; 469(7330):314-22. DOI: 10.1038/nature09781. View